phase 1_completion
saveKyowa Kirin Co Ltd — brentuximab vedotin (Phase I Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Cutaneous T-Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome
Data sources
globaldata
Found something off?
comments(0)
5-min edit window · permanent after that